Company ProfilePremium

Chemtrade Logistics Inc.

Company Profile Analysis

Ticker: CHE.UN.TO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Chemtrade Logistics Inc. - Company showcase

Year Founded & Workforce

2001

1,500 Employees

Chemtrade Logistics Inc. logo

Chemtrade Logistics Inc. Employee Contacts

18 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Chemtrade Logistics Inc. Overview

Chemtrade is a North American industrial chemicals producer and service provider whose economics rest on essential, hard-to-substitute inorganic chemistry. It is among the continent's largest suppliers of sulphuric acid, spent (regen) acid processing, inorganic water-treatment coagulants, sodium chlorate, sodium nitrite and sodium hydrosulphite, and a leading regional supplier of sulphur, chlor-alkali products and zinc oxide. Its customers are refineries, pulp mills, municipalities, miners, food processors and semiconductor fabs that buy on reliability and logistics as much as on price. Since 2021 management has simplified the portfolio, lifted Adjusted EBITDA from $280 million to a record $507 million in 2025, eliminated all convertible debt and resumed distribution growth and buybacks. The 2025 purchases of Polytec and Thatcher's alum assets, and a new Water Solutions reporting segment in 2026, tilt the mix toward steadier water markets. Chlor-alkali cyclicality and the North Vancouver chlorine site remain the principal swing factors for earnings and sentiment.


The company's own description

In its FY2025 Annual Report, Chemtrade describes itself as a diversified business providing industrial chemicals and services to customers in North America and around the world. It claims a position as one of North America's largest suppliers of sulphuric acid, regen acid processing services, inorganic coagulants for water treatment, sodium chlorate, sodium nitrite and sodium hydrosulphite. It also describes itself as a leading regional supplier of sulphur, chlor-alkali products and zinc oxide, and as a provider of industrial services such as value-added water solutions and the processing of by-products and waste streams. By the Q2 2026 release (August 12, 2026) the description had changed in two ways. The geographic framing became "North and South America", and the company added that it is a leading producer of high-purity sulphuric acid for the North American semiconductor industry.

Independent characterization

Chemtrade is best understood as three businesses with different earnings drivers.

Acid and Sulphur Products (ASP). This is a logistics-and-processing business as much as a manufacturing one. Chemtrade takes sulphuric acid produced as a by-product by smelters, removes and markets it, manufactures acid from sulphur at its own plants, regenerates spent acid for refinery alkylation units, and upgrades acid to ultrapure grades for semiconductor fabs. A material share of volume moves under risk-sharing or cost-pass-through contracts. This is why management notes that a change in acid price affects revenue more than earnings (FY2025 MD&A). The segment also holds sodium nitrite, sodium hydrosulphite, liquid sulphur dioxide, sodium bisulphite, hydrogen sulphide, sulphides and elemental sulphur marketing.

Water Solutions (WS). This segment makes inorganic coagulants (alum, ACH, PACl and ferric sulphate) from a dense network of small regional plants. Since November 2025 it also holds Polytec's turnkey treatment-solutions business, which serves food processors and municipalities. A significant portion of WS products is sold under annual fixed-price contracts that renew on a rolling basis (Q2 2026 release). Margins therefore lag input-cost moves in both directions.

Electrochemicals (EC). This is a power-intensive commodity business with structural cost advantages. Sodium chlorate is produced at Brandon, Manitoba, which the company calls its lowest-cost source. Chlor-alkali is produced at North Vancouver, British Columbia. A sodium chlorate and chlor-alkali complex in Espírito Santo, Brazil is tied to an adjacent pulp customer. Electricity is two-thirds to three-quarters of EC variable cost and salt almost a quarter (FY2025 MD&A). Earnings are driven by the "MECU netback" (the combined realized value of caustic soda, chlorine and HCl per electrochemical unit) and by the sodium chlorate price.

Revenue model

DimensionCharacterizationEvidence
Product vs. servicePredominantly product sales. Service revenue comes from regen acid processing (tolling-like), by-product removal, waste-stream processing and, since November 2025, Polytec's turnkey water solutionsFY2025 MD&A; Polytec releases
Subscription / licensingNone disclosed—
Contract structureMulti-year contracts with large customers; annual fixed-price contracts in water; risk-sharing supply contracts in merchant acid; index-linked caustic pricing with a one-quarter lag to the NE Asia spot indexFY2025 MD&A; Q2 2026 release
Customer concentration15 customers represent just under a quarter of revenue, concentrated in pulp and paper and oil refiningFY2025 MD&A
Pricing sensitivities (annual pre-tax)Sodium chlorate ±$50/MT ≈ $13.7 million; MECU ±$100 ≈ $17.0 million; sulphuric acid ±$10/tonne ≈ $9.8 million of revenue; electricity ±4% ≈ $3.7 million; salt +$2/tonne ≈ $0.9 million; sulphur +$10/tonne ≈ $1.3 million of costFY2025 MD&A
CurrencyA one-cent weakening of CAD against USD adds about $3.2 million to net earnings, $4.0 million to Adjusted EBITDA and $2.8 million to distributable cash, unhedgedFY2025 MD&A

Value chain position and end-markets

End-marketProducts suppliedSegment
Petroleum refining (alkylation)Regen acid services, sulphur, sodium bisulphiteASP
Pulp and paperSodium chlorate, caustic soda, sodium hydrosulphite, alumEC, ASP, WS
Municipal and industrial water treatmentAlum, ACH, PACl, ferric sulphate, liquid chlorine, turnkey solutionsWS, EC
Food processingPolytec treatment solutions, sodium nitriteWS, ASP
SemiconductorsUltrapure sulphuric acid (Cairo, Ohio; Tulsa, Oklahoma)ASP
Mining, base metals, fertilizer, industrialMerchant sulphuric acid, by-product removal servicesASP
Oil and gas (fracking, upgrading)HCl, caustic soda, sulphur servicesEC, ASP
Rubber, coatings, heat-transfer saltsSodium nitrite, zinc oxideASP

Chemtrade sits mid-stream. Upstream it buys sulphur, by-product acid from smelters, alumina sources (hydrate, aluminum), zinc, salt and electricity. Downstream it sells into the following markets.

Strategy

Stated strategy

The FY2025 MD&A describes a strategy of growing size, scale and diversity of earnings by improving the businesses already owned, and of acquiring when it makes economic and strategic sense. Organic levers are key new products, added capacity for existing products and productivity. The Chair's 2026 letter frames value creation as operational discipline, beginning with safety, combined with thoughtful capital allocation. The CEO's recurring formulation is operational excellence, organic growth supplemented by the 2025 acquisitions, a prudent balance sheet, and returning capital through distributions and buybacks. In the Q2 2026 release Mr. Rook described guidance as reflecting "the stability of our earnings, cash flows, and balance sheet".

Vision 2030

ElementDetailSource
LaunchMay 12, 2025, with Q1 2025 resultsQ1 2025 release
Headline targetMid-cycle Adjusted EBITDA of $550–$600 million by 2030Q2 2026 release
Growth cadence5–10% annual growth focusInvestor presentation summary (Quartr)
MeansOperational and commercial excellence; organic projects in water and ultrapure acid; acquisitions such as Polytec and ThatcherQ2 2026 release
Capital returnsDistribution growth and buybacks retained alongside leverage of about 2.5xFY2025 MD&A

Initiatives announced in the last 24 months

InitiativeDateDetailTarget or status
Water solutions organic expansionOngoing 2024–2026Small capacity projects in ACH, PACl and alum; 2026 growth capex of $40–$60 million focused on waterIn execution
Polytec acquisitionAug 14 / Nov 21, 2025US$150 million; turnkey solutions platform; cross-selling in U.S. and CanadaIntegration on plan
Thatcher Group alum assets2,025About US$30 million implied (US$180 million total less Polytec)Integration on plan
Cairo, Ohio UPA expansion2023–2025US$60–65 million; first North American plant to meet next-generation node qualityStarted up 2025; qualification and commercial ramp through 2026–2028
Tulsa, Oklahoma UPA upgrade2,025Quality improvement upgradesComplete; in customer certification
KPCT Arizona UPA joint venture2022 onwardProposed plant at Casa Grande; CHIPS Act funding applied forOn hold; JV impaired $3.8 million in 2024
North Vancouver long-term tenure2025–2026Port LOI (20-year term), rezoning adopted July 20, 2026; safety upgrades and new liquefaction$75–$125 million multi-year capex; lease not yet finalized; judicial review pending
Capital structure optimizationAug 2024 – Jun 2026$625 million of senior notes; credit facility to October 2030; all convertibles eliminatedComplete; further note refinancing under review
Unit buybacksJun 2024 onward8.9 million units bought in 2025 for $100.8 million; current NCIB of about 5.8 million units to April 16, 2027Pace moderated after Polytec
Distribution growthJan 2024, Jan 2025, Jan 2026+10%, +5%, +4% to $0.72 per unit annuallyThree consecutive annual increases
U.S. investor accessFeb 20, 2026OTCQX listingComplete
Safety programme2,025Full implementation of DuPont STOP; contractor recordables down more than 50%OIR 0.57; top quartile
Segment re-reportingQ1 2026WS disclosed separatelyComplete
Technology2,025Core technology transformation; early AI adoption in back-office functions; strengthened cyber governanceOngoing
Incentive redesign2,026Annual incentive refocused on distributable cash per unitEffective 2026

Cost programmes and medium-term targets

No discrete cost-reduction programme with a dollar target is disclosed. Management refers to ongoing reliability, productivity and pricing initiatives and reports unplanned-downtime costs at a historic low in 2025. Financial targets are the 2026 Adjusted EBITDA range of $485–$525 million, leverage near 2.5x, a payout ratio near 40%, and the Vision 2030 EBITDA range.

Products & Services

Chemtrade does not disclose list prices, launch years for commodity products, or product-level revenue. Where a field is "not publicly disclosed", that reflects the company's disclosure practice.

Acid and Sulphur Products (ASP)

Product / serviceDescription and capabilitiesTarget customersPricing modelNotes
Merchant sulphuric acidAcid manufactured from sulphur at Chemtrade plants plus by-product acid removed from smelters and marketed by Chemtrade; distributed by rail, truck and vesselFertilizer, mining and metals, pulp, industrial and water-treatment producersMix of fixed-period contract pricing and risk-sharing supply contractsA $10/tonne net price change moves North American revenue by about $9.8 million; 2025 strength came from price and volume and was the largest driver of record results
Regen (spent) acid processingRegeneration of spent sulphuric acid from refinery alkylation units and return of fresh acid; several plants are pipeline-connected to or adjacent to refineriesPetroleum refinersLong-term service contracts with cost pass-through elementsPrincipal sites include Beaumont (TX), Richmond (CA), Anacortes (WA), Toledo (OH), East St. Louis (IL)
Ultrapure sulphuric acid (UPA)Electronic-grade acid for wafer cleaning and etching. Cairo, Ohio was expanded and upgraded (budget US$60–65 million) to meet next-generation node requirements; Tulsa, Oklahoma received quality upgradesSemiconductor fabsQualification-based supply agreements; pricing not disclosedCairo construction and start-up completed in 2025; sales ramping to two advanced-node North American producers in H2 2026, per the Q2 2026 call summary
Sodium nitriteProduced at Syracuse, New York; used in heat-transfer salts, rubber chemicals, dyes, corrosion inhibition and food curingIndustrial and food customersContract and spotDescribed as one of North America's largest suppliers; the sodium nitrite CGU was impaired in Q2 2025; costs were higher in 2025
Sodium hydrosulphite (SHS)Reductive bleaching agent for mechanical pulp, textiles and clay; uses zinc dust feedstockPulp and paper, textile, mineralsContractDescribed as one of North America's largest suppliers
Elemental sulphur (marketing and handling)Removal, forming, handling and marketing of refinery and gas-plant sulphurRefiners and upgraders (supply side); acid producers (demand side)Fee and marketing marginFort McMurray and Fort Saskatchewan, Alberta are principal sites
Liquid sulphur dioxideProduced within the sulphur chainPulp, food, water treatmentContractChemtrade also purchases SO2 as a raw material at some sites
Sodium bisulphiteDechlorination and reducing agentWater treatment, refining, pulpContract—
Hydrogen sulphide and sulphidesH2S and sulphide salts; H2S is a toxic-inhalation-hazard productMining, chemical intermediatesContract—
Zinc oxideCo-product of the SHS chain; Chemtrade describes itself as a leading regional supplierRubber, ceramics, agricultureContract—
By-product and waste-stream processingRemoval and processing of industrial by-products and waste streamsRefining, metals and industrial generatorsService feesLegacy Marsulex capability
Divested: phosphorus pentasulphide (P2S5)Lubricant-additive intermediate——Sold November 8, 2023; contributed $40.3 million of revenue and $6.6 million of EBITDA in 2023
Divested: KCl, caustic pellets, vaccine adjuvantsSpecialty products——Sold Q4 2021

Water Solutions (WS)

Product / serviceDescription and capabilitiesTarget customersPricing modelNotes
Aluminum sulphate (alum)Workhorse coagulant for drinking water and wastewater clarification and for paper sizingMunicipalities, industrial water users, paper millsPredominantly annual fixed-price contracts renewing on a rolling basisThatcher Group alum assets acquired in 2025 to strengthen the position
Aluminum chlorohydrate (ACH)High-basicity, low-dose coagulantMunicipal and industrialAnnual contractsTarget of organic expansion capex
Polyaluminum chloride (PACl)Pre-polymerized coagulant with a wide pH operating rangeMunicipal and industrialAnnual contractsTarget of organic expansion capex
Ferric sulphateIron-based coagulant; phosphorus and arsenic removalMunicipal and industrialAnnual contracts—
Turnkey water treatment solutions (Polytec)Chemistry plus equipment and on-site service for wastewater and process water; founded more than 30 years ago; operations in four U.S. states at announcementPrimarily food processing, also municipalSolutions and service contractsAcquired November 21, 2025 for US$150 million; cross-selling into Chemtrade's U.S. and Canadian footprint is the stated thesis

Electrochemicals (EC)

Product / serviceDescription and capabilitiesTarget customersPricing modelNotes
Sodium chlorateFeedstock for chlorine dioxide used in elemental-chlorine-free pulp bleaching; produced at Brandon (MB), Prince George (BC) and BrazilBleached pulp millsMulti-year contractsNorth American volumes of 273,000 MT in 2025 and 270,000 MT in 2024; the Prince George facility was impaired in Q2 2025
Caustic sodaCo-product of chlor-alkali electrolysis at North Vancouver and BrazilPulp and paper, alumina, water treatment, industrialIndexed to the NE Asia spot price with a one-quarter lag2026 index assumption cut from US$450 to US$370 per tonne; 2025 actual US$435; 2024 US$385
Chlorine (including liquid chlorine)Co-product; liquid chlorine for municipal water disinfectionMunicipal water utilities, industrialContractNorth Vancouver supplies about 70% of the chlorine used for drinking-water purification in B.C. and Alberta (press reports); a toxic-inhalation-hazard product
Hydrochloric acid (HCl)Chlorine upgraded to HClOil and gas (fracking), steel, foodSpot and contractHCl and chlorine drove about 80% of the Q2 2026 MECU netback decline
Brazil sodium chlorate and chlor-alkaliTwo plants at one site in Espírito Santo, sharing services with an adjacent customerBrazilian pulp producer(s)Long-term supplyHigher revenue and margins in Q2 2026; exposed to Brazil's deregulated power market

Aggregate North American chlor-alkali volume was 170,000 MECU in 2025 and 172,000 in 2024. The 2026 assumption was raised from 171,000 to 180,000.

Financial Narrative

IFRS; CAD millions unless stated. Sources: FY2025 Annual Report and Q4 2025 release (FY2023–FY2025); Q4 2023 release (FY2022–FY2023); FY2022 Annual Report (FY2021–FY2022); Q4 2021 release (FY2021).

Income statement

FY2021 distributions per unit reflect the $0.05 monthly rate then in force. FY2023 operating income includes the $24.3 million gain on the P2S5 sale. FY2025 operating income is after a $43.5 million PPE impairment.

Growth rates. Revenue CAGR FY2021–FY2025 is 9.9%. Adjusted EBITDA CAGR over the same period is 16.0%, consistent with the 16% cited in the company's investor presentation.

Commentary.

Revenue: The 2022 step-up of 32.5% came from pricing across both segments in a tight chlor-alkali and sulphur market. Revenue has been stable to higher since, despite the P2S5 divestiture ($40.3 million of 2023 revenue). The 2025 increase of $210.7 million was driven by merchant acid, water products and regen acid. $29.2 million was currency.

Adjusted EBITDA: The margin rose almost seven points between 2021 and 2023 and has since eased to 25.4% as mix shifted toward lower-margin acid and water revenue. Management presents about $415 million as the pre-2025 mid-cycle level and now targets $550–$600 million by 2030.

Net earnings: These are much more volatile than EBITDA because convertible debentures were carried at fair value. Fair-value changes ran through net finance costs: $26.5 million of charges in 2025 and $18.6 million in 2024. With the last convertibles redeemed in June 2026 this noise disappears. Q2 2026 net finance costs fell to $10.6 million from $35.6 million.

Tax: The 2025 effective rate was 10.4% against a 25.0% statutory rate. The main cause was recognition of previously unrecognized U.S. interest-expense carryforwards after the OBBBA enactment. This is a one-off benefit, partly offset by BEAT.

Impairments: 2021 saw the sodium chlorate impairment. 2025 saw $43.5 million for the Prince George sodium chlorate facility and the sodium nitrite CGU. 2024 saw $3.8 million for the KPCT joint venture.

Balance sheet

Short/long split: at December 31, 2025 no long-term debt principal was due within one year. The only debt-like current items were lease liabilities of $58.7 million and the fair-valued 2028 convertibles of $31.0 million. At December 31, 2024 the convertible debentures ($356.6 million at fair value) were classified as current, which explains the large IFRS working-capital deficit that year. Goodwill is not separately broken out in the sources reviewed.

June 30, 2026 update (Q2 2026 release). Long-term debt principal $1,110.8 million; debentures nil; lease liabilities $185.4 million; cash $44.5 million; net debt $1,251.7 million; net debt to LTM Adjusted EBITDA 2.55x; undrawn credit capacity about $410 million (US$289 million).

Commentary. The balance sheet story is a reshaping of the debt stack. Between 2022 and mid-2026 Chemtrade retired more than $500 million of dilutive convertible debentures and replaced them with $625 million of conventional senior notes and bank debt. It also funded US$180 million of acquisitions and more than $155 million of buybacks. Leverage rose from 1.7x to 2.55x, back to management's stated target of about 2.5x. Intangibles rose $189 million in 2025 on Polytec goodwill and customer relationships and the Thatcher customer relationships. A $66.0 million non-current income tax receivable reflects deposits with the CRA under dispute.

Cash flow

FY2025 acquisitions comprise $212.8 million for Polytec and $39.1 million of intangible assets acquired (Thatcher customer relationships). For H1 2026: operating cash flow $134.3 million; maintenance capex $71.4 million; growth capex $17.2 million; distributable cash $82.5 million ($0.7355 per unit); payout ratio 49%.

Commentary. Operating cash flow has held in a $340–$400 million band for four years. The quality of the distribution is high. In 2025 Chemtrade paid $78.9 million against $228.0 million of distributable cash and spent more on buybacks than on distributions. The first half of 2026 looks weaker because maintenance capex was front-loaded ($71.4 million against $43.9 million) and EC EBITDA fell. Management guides to a full-year payout near 40%.

Ratios

ROIC. The company defines ROIC for incentive purposes as Adjusted EBITDA divided by average debt (less lease liabilities) plus average book equity. Annual ROIC values are not publicly disclosed. The 2025–2027 PSU scale sets threshold at 11%, target at 15.75% and maximum at 17.33%. The 2023–2025 award measured a 62.6% improvement over the prior three-year average (2026 Circular). An independent estimate on that definition for FY2025, using average principal debt of about $850 million and average equity of about $797 million, gives roughly 31%. This is an EBITDA-based measure, not a post-tax NOPAT ROIC, and is not comparable to conventional ROIC.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentPeriod in useContents

Sulphur and Water Chemicals (SWC)

Through FY2025

Merchant, regen and ultrapure sulphuric acid; sodium hydrosulphite; elemental sulphur; hydrogen sulphide; sodium bisulphite; sulphides; processing services; alum, ACH, PACl, ferric sulphate; sodium nitrite; turnkey water solutions

Acid and Sulphur Products (ASP)

From Q1 2026

Merchant, regen and ultrapure acid; sodium nitrite; all other sulphur-related products; other processing services

Water Solutions (WS)

From Q1 2026

Inorganic coagulants (alum, ACH, PACl, ferric sulphate) and value-added water solutions (Polytec)

Electrochemicals (EC)

Unchanged

Sodium chlorate and chlor-alkali (caustic soda, chlorine, HCl) for pulp and paper, oil and gas and water treatment; North and South America

Corporate

Unallocated

Treasury, finance, IT, HR, legal and risk, EHS support, LTIP, hedging gains and losses

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2024FY2025

SWC revenue (CAD Mn)

1,038.21,230.7

EC revenue (CAD Mn)

748.9767.0

Total revenue (CAD Mn)

1,787.01,997.8

SWC gross profit (CAD Mn)

196.7198.8

EC gross profit (CAD Mn)

233.8261.3

SWC Adjusted EBITDA (CAD Mn)

270.4288.6

EC Adjusted EBITDA (CAD Mn)

314.1345.7

Corporate costs (CAD Mn)

-113.7-126.9

Total Adjusted EBITDA (CAD Mn)

470.8507.4

SWC Adjusted EBITDA margin (%)

26.023.4

EC Adjusted EBITDA margin (%)

41.945.1

SWC gross margin (%)

19.016.2

EC gross margin (%)

31.234.1

SWC revenue growth YoY (%)

—18.5

EC revenue growth YoY (%)

—2.4

SWC share of revenue (%)

58.161.6

EC share of revenue (%)

41.938.4

EC sodium chlorate volume, North America (000 MT)

270273

EC chlor-alkali volume, North America (000 MECU)

172170

Revenue by Segment and Segment Margins & Growth (%) (Quarterly)

MetricQ1 2025Q1 2026Q2 2025Q2 2026

ASP revenue (CAD Mn)

153.1180.3163.4216.4

WS revenue (CAD Mn)

——139.1181.9

EC revenue (CAD Mn)

195.3—194.2180.4

Total revenue (CAD Mn)

466.3503.0496.7578.7

ASP Adjusted EBITDA (CAD Mn)

36.040.243.553.2

WS Adjusted EBITDA (CAD Mn)

——32.737.0

EC Adjusted EBITDA (CAD Mn)

——92.161.2

Corporate costs (CAD Mn)

——-30.3-24.1

Total Adjusted EBITDA (CAD Mn)

120.1113.5138.0127.3

ASP Adjusted EBITDA margin (%)

23.522.326.624.6

WS Adjusted EBITDA margin (%)

——23.520.3

EC Adjusted EBITDA margin (%)

——47.433.9

Revenue by Segment

MetricQ4 2022Q4 2023Q4 2024Q4 2025

SWC revenue (CAD Mn)

264.7243.8260.1323.1

EC revenue (CAD Mn)

192.0178.2186.4179.0

SWC Adjusted EBITDA (CAD Mn)

57.140.862.560.7

EC Adjusted EBITDA (CAD Mn)

78.373.383.571.6

Corporate costs (CAD Mn)

-31.1-29.4-37.3-34.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (CAD Mn)

1,368.51,813.41,846.81,787.01,997.8

Revenue growth YoY (%)

-0.832.51.8-3.211.8

Cost of sales and services (CAD Mn)

———1,356.51,537.7

Gross profit (CAD Mn)

———430.6460.1

Selling and administrative expenses (CAD Mn)

———183.3156.6

Operating income (CAD Mn; FY2022–FY2023 derived)

—219.2315.4243.4260.0

Adjusted EBITDA (CAD Mn)

280.4430.9502.6470.8507.4

Depreciation and amortization (CAD Mn)

—217.0217.5188.5220.1

Net finance costs (CAD Mn)

—50.024.072.6104.5

Pre-tax income (CAD Mn; FY2022–FY2023 derived)

—169.2291.4170.8155.5

Income tax expense (CAD Mn)

—60.142.143.916.1

Net earnings (CAD Mn)

-235.2109.1249.3126.9139.4

Basic EPU (CAD)

-2.311.012.151.071.22

Diluted EPU (CAD)

-2.310.991.521.041.22

Distributions declared per unit (CAD)

0.600.600.600.660.69

Gross margin (%)

———24.123.0

Operating margin (%)

—12.117.113.613.0

Adjusted EBITDA margin (%)

20.523.827.226.325.4

Net margin (%)

-17.26.013.57.17.0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (CAD Mn)

2,049.02,157.12,109.22,284.42,531.3

Cash and equivalents (CAD Mn)

—72.621.525.527.4

Long-term debt, principal (CAD Mn)

—370.0246.5343.3991.2

Convertible debentures, principal (CAD Mn)

—517.4425.6340.025.5

Total debt, principal (CAD Mn)

—887.4672.1683.31,016.8

Lease liabilities, current plus long-term (CAD Mn)

—139.6179.9206.4191.0

Net debt, company definition (CAD Mn)

—954.5830.5864.21,180.3

Unitholders' equity (CAD Mn)

———818.4775.1

Intangible assets including goodwill (CAD Mn)

———542.0731.2

Property, plant and equipment (CAD Mn)

———1,088.11,101.0

Current assets (CAD Mn)

———334.7414.4

Current liabilities (CAD Mn)

———798.0462.5

Working capital, IFRS current assets less current liabilities (CAD Mn)

———-463.3-48.1

Net working capital, company non-IFRS (CAD Mn)

———-106.7-17.2

Cash Flow and Per-Share Data

MetricFY2022FY2023FY2024FY2025

Cash flow from operating activities (CAD Mn)

369.2401.5342.1355.1

Capital expenditures (CAD Mn)

115.4166.4180.1176.6

Maintenance capex (CAD Mn)

99.8104.2104.5123.5

Growth capex (CAD Mn)

21.662.181.348.2

Free cash flow, CFO less capex (CAD Mn; derived)

253.8235.1162.0178.5

Lease payments (CAD Mn)

52.458.365.470.0

Cash interest (CAD Mn)

51.742.445.754.9

Cash tax (CAD Mn)

12.014.742.131.0

Distributable cash after maintenance capex (CAD Mn)

215.1283.0213.1228.0

Distributable cash per unit (CAD)

1.982.441.801.99

Payout ratio (%)

30253735

Distributions paid, net of DRIP (CAD Mn)

—58.076.678.9

Unit repurchases under NCIB (CAD Mn)

——54.5100.8

Business and intangible acquisitions (CAD Mn)

——0.0252.0

Financial Ratios (x) and Returns & Leverage Ratios (%)

MetricFY2022FY2023FY2024FY2025

Net debt / Adjusted EBITDA (x; company)

2.21.71.82.3

Interest coverage, Adjusted EBITDA / cash interest (x; derived)

8.311.910.39.2

Return on equity (%; derived, average equity)

———17.5

Return on assets (%; derived, average assets)

5.211.75.85.8

Asset turnover (x; derived, average assets)

0.860.870.810.83

Current ratio (x; derived)

——0.420.90

Total debt / equity (x; derived, principal debt)

——0.831.31

Cash conversion cycle (days; approximate, year-end balances)

——-22-13

Segment Overview — ASP

SegmentCanadaUnited StatesSouth America

ASP

Sulphur and acid services in Alberta; by-product acid from Canadian smelters

Regen plants on the Gulf Coast, West Coast and Midwest; UPA in Ohio and Oklahoma; sodium nitrite in New York

—

WS

Coagulant plants serving Canadian municipalities

Largest coagulant network; Polytec in the U.S. Southeast; Thatcher alum assets

—

EC

All North American production (Brandon, North Vancouver, Prince George); a meaningful share is exported to the U.S.

Sales destination only

Brazil complex: 100% of South American revenue

Capital Markets

ItemValueSource

Unit price

CAD 14.41 close on September 30; CAD 14.23 intraday on October 1

Morningstar

52-week range

CAD 13.18 – 18.43

Morningstar; Yahoo

Market capitalization

About CAD 1.60 billion

Morningstar

Units outstanding

About 112.2 million

Morningstar

Beta (5-year monthly)

1.06

Yahoo

Annualized distribution / yield

CAD 0.72 / about 5.0%

Yahoo

Average daily volume

About 234,000 units

Yahoo

Number of analysts

7

Investing.com

Average 12-month target

CAD 19.79 (about 37–39% above the current price)

Yahoo; Investing.com

Target range

CAD 18.50 – 22.50

Yahoo

Next-year EPS consensus

CAD 1.31

Stockopedia

Covering brokers identified

CIBC, National Bank, Scotiabank, Desjardins, Raymond James

Call transcripts; MarketBeat

Share Price & Returns

PeriodPerformanceSource and comment

1 year

About +6% to +9% price-only

Units traded near $13.5 in early October 2025; one aggregator cited +9.2% in early September 2026

3 years

The unit price rose 61% over January 1, 2023 – December 31, 2025; the price to October 2026 was not separately verified

2026 Circular

2026 year to date

About -3% from the December 31, 2025 close of $14.75, after a high of $18.43

FY2025 MD&A; Morningstar

Valuation Multiples

MultipleChemtradeBasis

P/E (trailing)

About 11.3x

Yahoo; trailing EPU $1.27

P/E (normalized)

13.0x

Morningstar

EV / LTM Adjusted EBITDA

About 5.8x

Derived: EV about $2.85 billion; LTM Adjusted EBITDA $490.2 million

EV / LTM sales

About 1.35x

Derived: LTM revenue about $2,116 million

Price / book

2.0x

Morningstar

Price / sales

0.77x

Morningstar

Price / distributable cash per unit (FY2025)

About 7.2x

Derived: $14.3 / $1.99

Per-Share Data and Capital Markets Data (CAD)

MetricFY2021FY2022FY2023FY2024FY2025

Distributions declared per unit (CAD)

0.600.600.600.660.69

Monthly rate at year-end (CAD)

0.050.050.050.0550.0575

Payout ratio (%)

—30253735

Total distributions declared (CAD Mn)

——70.178.378.9

Capital Programmes

ProgrammeAuthorizationPeriodActivity

2024 NCIB

Up to 11.7 million units

June 2024 – June 2, 2025

11.2 million units purchased

2025 NCIB

Up to 11.2 million units

To August 18, 2026

About 2.9 million purchased by December 31, 2025 per the MD&A's Recent Developments; 1.9 million per its Capital Allocation section and 2.8 million per the Q4 release (the sources conflict)

Current NCIB

About 5.8 million units

Terminates April 16, 2027

About 0.9 million bought in Q2 2026; about 4.6 million remaining at August 11, 2026

Credit Ratings

AgencyEntity / instrumentRatingOutlookDate

Morningstar DBRS

Chemtrade Logistics Inc. — Issuer Rating

BB (high)

Stable

Assigned August 21, 2024

Morningstar DBRS

Senior Unsecured Notes

BB (recovery rating RR5)

Stable

Finalized August 30, 2024

Moody's / S&P / Fitch

—

No rating identified

——

Capital Instruments

InstrumentCouponMaturityPrincipal at Dec 31, 2025 (CAD Mn)Principal at Jun 30, 2026 (CAD Mn)

2028 Convertible Debentures

7.00%

Jun 30, 2028

25.50.0

2028 Non-Convertible Debentures (subordinated)

7.00%

Jun 30, 2028

73.973.9

Senior Unsecured Notes (CLI)

6.375%

Aug 28, 2029

375.0375.0

Revolving Credit Facilities (about US$600 million)

Floating; 4.2% weighted average at Dec 31, 2025

Oct 31, 2030

292.3411.9

Senior Unsecured Notes (CLI)

5.750%

Oct 1, 2032

250.0250.0

Total long-term debt principal

——991.21,110.8

Analyst Conclusions

Management guidance (as updated August 12, 2026)

Item2026 guidance (Feb 2026)2026 guidance (Aug 2026)2025 actualH1 2026 actual
Adjusted EBITDA (CAD M)485–525485–525507.4240.8
Maintenance capex (CAD M)120–150130–140123.571.4
Growth capex (CAD M)35–5540–6048.217.2
Lease payments (CAD M)70–8070–8070.035.4
Cash interest (CAD M)65–7565–7554.931.9
Cash tax (CAD M)35–4530–4031.019.7
N.A. MECU sales volumes171,000180,000170,000—
MECU netback change vs. 2025 (CAD per MECU)-155-275——
NE Asia caustic index (USD per tonne)450370435—
N.A. sodium chlorate production (MT)254,000260,000273,000—
USD/CAD1.3751.3751.397—
LTIP cost (CAD M)22–2818–2529.4—
Year-end net debt / EBITDAAbout 2.5xAbout 2.5x2.3x2.55x
Implied payout ratioAbout 45%About 40%35%49%

Reading the revision. The EBITDA range is unchanged, but its composition has shifted materially. Chlor-alkali price assumptions were cut hard: caustic index down US$80 per tonne and netback down a further $120 per MECU. The offsets are higher chlor-alkali and chlorate volumes, stronger acid earnings, Polytec and lower LTIP cost. H1 delivered $240.8 million, so the midpoint requires about $264 million in H2 against $249.4 million in H2 2025. A reasonable central case is the lower half of the range.

Consensus expectations

Consensus next-year EPS is $1.31 against trailing $1.27, implying modest growth. The average price target of $19.79 implies the sell-side expects both execution toward Vision 2030 and multiple expansion. Detailed consensus EBITDA and revenue estimates are not publicly available without a subscription and are not reported.

Bull case

  1. Water and UPA re-rate the mix. WS is now disclosed separately. It grew revenue 31% in Q2 2026 and should regain margin as fixed-price contracts renew. Cairo begins revenue contribution in H2 2026 and is expected to fill through 2027–2028. Both are less cyclical than EC.

  2. Per-unit compounding. With no convertibles, a payout near 40% and a standing NCIB, free cash after distributions of roughly $100–$150 million a year can fund bolt-on acquisitions at about 6.5x EBITDA and retire units trading under 6x EV/EBITDA.

  3. North Vancouver certainty unlocks value. The adopted bylaw converts a 2030 cliff into a horizon to as late as 2046 for an asset that supplies about 70% of Western Canada's drinking-water chlorine.

Bear case

  1. EC is rolling over. Q2 2026 EC EBITDA fell $30.9 million year over year. Guidance now embeds a $275 per MECU netback decline. Sodium chlorate faces new competition and shrinking pulp demand, with Prince George already impaired.

  2. Legal and capital risk at North Vancouver. A judicial review could reopen the rezoning. The port lease is still only an LOI. $75–$125 million of capex is required whatever the outcome.

  3. Quality of the 2025 peak. Management itself attributes part of 2025 acid strength to external factors. Leverage is back to 2.55x. Corporate costs are high. Any shortfall against a back-half-weighted 2026 would test the credibility of the $550–$600 million 2030 target.

Catalysts and monitorables (next 12 months)

ItemTimingWhy it matters
Q3 2026 resultsNovember 11, 2026First test of the H2 recovery; WS margin recovery; EC netbacks
2027 guidance and distribution decisionJanuary 2027A fourth consecutive increase would signal confidence
B.C. Supreme Court proceedings on the rezoningLate 2026 – 2027Binary risk to post-2030 chlorine production
Definitive Port Authority leaseNot datedConverts the LOI into tenure
Cairo UPA qualification milestones and first volumesH2 2026 – 2027Evidence for the UPA growth pillar
NE Asia caustic index and HCl pricingQuarterlyPrimary EC earnings driver with a one-quarter lag
CUSMA review outcome and U.S. tariff policy2,026Cross-border flows and alumina input costs
Further water acquisitionsOpportunisticVision 2030 inorganic component
Note refinancingOpportunisticLower coupon and longer tenor
CRA tax appealNot dated$66.0 million refund or write-off
NCIB paceMonthlySignals management's view of value against leverage

Analyst verdict

Chemtrade in late 2026 is a materially better company than the over-levered, convertible-funded trust of 2020–2021, and the market only partly credits it. Over five years Adjusted EBITDA rose from $280 million to $507 million, more than $500 million of dilutive convertibles were retired, distributions were raised three times and almost nine million units were repurchased in 2025 alone. Management has also been candid: it described 2023 as above mid-cycle and flagged that 2025's acid strength was partly external. That candour gives its $485–$525 million 2026 range and $550–$600 million 2030 ambition more weight than typical targets.

The debate is about composition. Electrochemicals delivered more than half of segment EBITDA in 2025 at a 45% margin, and it is now deteriorating. Chlorine and HCl netbacks are falling, sodium chlorate faces structural pressure, and the single chlor-alkali site carries legal, lease and capital uncertainty despite July's rezoning win. Against that, Acid and Sulphur Products and Water Solutions are growing more than 30% in revenue terms, Polytec was bought at a sensible multiple, and ultrapure acid offers a credible high-return growth leg.

At roughly 5.8x EV/EBITDA, an 11x trailing P/E and a 5% yield covered more than twice, the units discount a meaningful EC decline and assign little value to the water and semiconductor options. The balance sheet at 2.55x is at target, not under-levered, so the next leg must come from earnings, not financial engineering.

The distribution appears secure. Downside is cushioned by cash generation. Upside depends on three things an investor can track: WS margin recovery, Cairo's ramp, and a clean legal outcome at North Vancouver. Failure on the third is the principal scenario that would break the thesis.


Data gaps flagged for follow-up from the FY2025 Annual Report notes and the 2025 AIF: geographic revenue split (FY2023–FY2025); FY2023 full-year segment split; FY2021–FY2023 gross profit and equity; goodwill balance; full facility list and headcount history; Summary Compensation Table totals; top institutional holders; GHG targets and ESG ratings; peer financials and multiples; date and terms of the Thatcher transaction and of the April 2026 NCIB. All figures are public-source and should be re-checked against SEDAR+ filings before investment or transactional use.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure and backgroundEducationAge

Scott Rook

President and CEO; Trustee

CEO since March 1, 2021; COO September 2019 – February 2021. Previously SVP Commercial Operations at Ascend Performance Materials (2010–2019); 17 years at Eastman Chemical. Resident of Conroe, Texas

MBA (Finance), Auburn University; B.S. Industrial Engineering, University of Tennessee, Knoxville

60

Rohit Bhardwaj

Chief Financial Officer

Long-serving CFO (aggregators indicate about 20 years); oversees finance, IT and legal

MBA; CMA (U.K.); FCCA (U.K.); CPA (CGA)

—

Tim Montgomery

Group Vice-President, Manufacturing and Engineering

Leads manufacturing, engineering, Responsible Care and operational excellence

——

Alan Robinson

Group Vice-President, Commercial

Leads commercial, pricing, supply chain, procurement and Brazil

——

Susan Paré

General Counsel and Corporate Secretary (retired December 31, 2025)

Led legal and environmental risk

——

Benjamin T. Burford

Corporate Secretary (signatory of the March 20, 2026 circular)

———

Endri Leno

Vice President, Investor Relations

IR contact on 2026 releases

——

“—” = not publicly disclosed.

Directors' Remuneration

ExecutiveBase salaryAnnual incentive paid (CAD)Incentive as % of target2025–2027 LTI grant value (CAD)2023–2025 LTI realized payout (CAD)

Scott Rook

USD 930,000 (CAD 1,299,610)

2,237,266143.5%4,173,9709,294,628

Rohit Bhardwaj

CAD 533,000

495,432143.0%880,0002,725,447

Tim Montgomery

USD 428,500 (CAD 598,799)

468,657142.3%690,8641,890,227

Susan Paré

CAD 378,200

269,425142.5%385,0001,055,008

Alan Robinson

USD 415,800 (CAD 581,051)

403,256138.8%647,6851,702,079

Governance Detail

TrusteeRoleIndependentSinceAgeBackgroundCommitteesEquity held (units plus DSUs; value at CAD 15.00)

Douglas Muzyka

Chair

Yes

Nov 13, 2020

71

Former SVP and Chief Science and Technology Officer, DuPont; former head of DuPont Greater China, Canada and Mexico; director of CCL Industries and Stella-Jones; Ph.D. chemical engineering (Western Ontario)

None (Chair)

201,902 / $3.03M

Lucio Di Clemente

Trustee

Yes

Jul 7, 2009

67

CPA, CA; corporate financial adviser; Chair of Corby Spirit and Wine; MBA (Toronto)

Audit; Governance and Nominating (chair)

199,991 / $3.00M

Daniella Dimitrov

Trustee

Yes

May 15, 2020

56

Chief Strategy and Risk Officer, Equinox Gold; former mining CEO and CFO; director of Nexa Resources; LL.B., Global EMBA (Kellogg-Schulich)

Audit (chair); Responsible Care

151,903 / $2.28M

Luc Doyon

Trustee

Yes

May 10, 2022

66

34 years at Air Liquide; former CEO of Air Liquide Canada and of the group's welding division; director of Lassonde Industries and Hydro-Québec; B.Eng. (Polytechnique Montréal)

Responsible Care (chair); Human Capital and Compensation

56,948 / $0.85M

Gary Merasty

Trustee

Yes

Feb 20, 2024

61

CEO, Peter Ballantyne Group of Companies; former MP and Grand Chief, Prince Albert Grand Council; director of Bird Construction

Human Capital and Compensation; Governance and Nominating

27,623 / $0.41M

Emily Moore

Trustee

Yes

Jul 1, 2019

56

Director, Troost Institute, University of Toronto; formerly Hatch and Xerox; director of International Petroleum Corp.; Rhodes Scholar, D.Phil. (Oxford)

Human Capital and Compensation (chair); Governance and Nominating

147,973 / $2.22M

Suzann Pennington

Trustee

Yes

Jan 9, 2025

64

Former Managing Director and CIO, CIBC Global Asset Management (about $110 billion); Ontario Pension Board director; CFA, B.Math (Waterloo)

Audit; Responsible Care

26,935 / $0.40M

Scott Rook

CEO

No

Mar 1, 2021

60

See 9.1

—

681,382 units and RSUs / $10.22M

Board & Management Changes

DateChangeContext

January 9, 2025

Suzann Pennington appointed trustee

Adds capital-markets expertise

April 1, 2025

CEO compensation re-denominated in USD

CEO is a U.S. resident; reduces currency volatility in pay

May 13, 2025

Katherine Rethy retires from the board

Planned retirement

September 4, 2025

Committee reshuffle: Doyon to Human Capital and Compensation; Pennington to Audit

Outcome of the 2024 governance review

December 31, 2025

Susan Paré retires as General Counsel

Benjamin T. Burford signs as Corporate Secretary from March 2026

Competitive Landscape

Competitors by Segment

Product lineNamed competitorsChemtrade's relative position

Regen acid services

Ecovyst Inc.; Veolia North America Regeneration Services

One of the three principal North American regenerators; among the largest by its own description

Merchant sulphuric acid

NorFalco (Glencore); Southern States Chemical; Ecovyst; smelter-direct sales

Among the largest marketers; differentiated by by-product offtake contracts and logistics

Ultrapure sulphuric acid

PVS Chemicals; Kanto group affiliates; BASF and other Asian and European importers

Self-described leading North American producer for semiconductors

Inorganic coagulants

USALCO; Kemira Oyj; PVS Chemicals; GEO Specialty Chemicals; Hawkins, Inc.; Holland Company; C&S Chemicals; Thatcher (remaining lines)

Among the largest North American suppliers; regional plant density is the moat

Water treatment solutions

Hawkins, Inc.; Solenis; Ecolab (Nalco Water); Veolia Water Technologies; regional providers

New entrant through Polytec; niche in food processing in the U.S. Southeast

Sodium chlorate

Nouryon; ERCO Worldwide; Kemira

Among the largest North American producers; Brandon is a low-cost hydro-powered asset

Chlor-alkali

Olin Corporation; Occidental Chemical (OxyChem); Westlake Corporation; ERCO Worldwide; Shintech

Small regional producer with a strong Western Canada position, especially in liquid chlorine for water

Sodium nitrite

Imports from BASF and Asian producers

Principal North American producer

Sodium hydrosulphite

Imports; limited domestic competition

Among the largest North American suppliers

Peer Comparison FY2025

CompanyRevenueRevenue growthEBITDA marginComment

Chemtrade (FY2025)

CAD 1,997.8 million

+11.8%

25.4% (Adjusted)

Record year

Company Snapshot

$1,427M

Revenue

1,500

Employees

2001

Founded

Toronto, Canada

Headquarters

SWOT Analysis

Strengths

  • Record and resilient earnings. Adjusted EBITDA of $507.4 million in 2025, the highest since inception; a 16% CAGR since 2021 (FY2025 MD&A).
  • Strong cash conversion. Distributable cash of $228.0 million against $78.9 million of distributions; payout ratio 35% (FY2025).
  • Cleaned-up capital structure. Convertible principal cut from $517.4 million (2022) to nil (June 30, 2026); credit facility to October 2030; notes due 2029 and 2032.
  • High-margin EC franchise. EC Adjusted EBITDA margin of 45.1% in FY2025, anchored by Brandon's low-cost power.
  • Leading positions across six product lines, as claimed in every filing, with 15 large customers under predominantly multi-year contracts.
  • Top-quartile safety. OIR of 0.57 in 2025, third consecutive top-quartile year; contractor recordables down more than 50% (2026 Circular).
  • Aligned management. CEO holds 10.2x salary in units and RSUs; 60% of LTI is performance-conditioned on ROIC and relative return.

Weaknesses

  • Asset concentration. One site each for North American chlor-alkali and for most sodium chlorate (FY2025 MD&A risk section).
  • Margin dilution. Consolidated Adjusted EBITDA margin fell from 27.2% (2023) to 25.4% (2025). Q2 2026 EBITDA fell 7.8% on revenue up 16.5%.
  • Recurring impairments. $43.5 million in 2025 (Prince George, sodium nitrite); the 2021 sodium chlorate impairment; $3.8 million on the Arizona JV.
  • High corporate cost and LTIP volatility. Corporate costs of $126.9 million in 2025, 25% of EBITDA; LTIP expense of $29.4 million varies with the unit price.
  • Negative working capital and thin cash. Cash of $27.4 million at year-end 2025; reliance on the revolver and receivables factoring.
  • Limited disclosure. No R&D, patent, market share or product-level revenue data. The trust structure and tax complexity (SIFT, BEAT, CRA dispute) raise analytical friction.

Opportunities

  • Water roll-up. Polytec bought at about 6.5x EBITDA; management cites multiple further opportunities.
  • UPA ramp. Cairo sales to two advanced-node producers begin in H2 2026, with the facility expected to fill through 2027–2028 (Q2 2026 call summary).
  • Contract repricing in WS. Rolling renewals should recover 2026's input-cost squeeze over the next few quarters (Q2 2026 release).
  • Refinancing. Management is evaluating refinancing of outstanding notes; the 6.375% 2029 notes become callable at par after August 28, 2028 and at a premium before.
  • Valuation gap. Units trade near 5.8x EV/LTM Adjusted EBITDA and a 5% yield, against a consensus target of $19.79.
  • North Vancouver certainty. The adopted bylaw permits liquid chlorine to as late as 2046, enabling safety investment and securing a critical water-treatment supply position.

Threats

  • Judicial review of the July 20, 2026 bylaw (petition filed July 29, 2026) and an unfinalized port lease.
  • Chlor-alkali downcycle. 2026 MECU netback assumption cut to $275 below 2025 from $155 below; caustic index assumption cut from US$450 to US$370.
  • Trade policy. U.S. tariffs on Canadian goods and the CUSMA review; Chemtrade exports chlor-alkali, acid and chlorate to the U.S.
  • Rail and labour disruption. The 2024 Canadian rail stoppage cost $5.8 million; 31% of the workforce is unionized across 30 units.
  • Pulp industry contraction reducing chlorate and caustic demand.
  • Catastrophic hazard exposure. Chlorine, H2S and SO2 transport; management flags "nuclear" jury verdicts and rising insurance costs.
  • Climate and seismic exposure. Gulf Coast hurricanes, Alberta wildfires (Fort McMurray), B.C. flooding and West Coast earthquakes.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 1, 2025CEO pay re-denominated in USDGovernance and retention
Apr 10, 2025LOI with Vancouver Fraser Port Authority to extend the North Vancouver lease to end-2044First step toward resolving the principal asset-tenure risk
May 12, 2025Q1 2025: revenue $466.3 million; Adjusted EBITDA $120.1 million; guidance moved to the upper end of $430–$460 million; Vision 2030 launchedStrategic reset to growth
May 13, 2025AGM; say-on-pay 96.5% in favour; K. Rethy retiresGovernance stability
May 22, 2025National Bank raises target to $17.00 (outperform)Sell-side endorsement
June 20252024 NCIB expires with 11.2 million of 11.7 million units purchasedBuyback nearly fully used
Q2 2025$43.5 million PPE impairment (Prince George sodium chlorate facility; sodium nitrite CGU)Signals structural pressure in chlorate and nitrite costs
Aug 14, 2025Q2 2025: revenue $496.7 million; Adjusted EBITDA $138.0 million; guidance raised to $475–$500 million; Polytec agreed; new NCIB; 2026 debentures to be redeemedLargest acquisition since 2017
Aug 15–18, 2025Scotiabank upgrades to outperform; Desjardins and Raymond James raise targets to $16.00Rating momentum
Aug 2025New NCIB for up to 11.2 million units to August 18, 2026Continued buybacks
Q3 2025$100.0 million of 6.50% 2026 convertible debentures redeemed at parDilution overhang reduced
Sep 22, 2025SIBs launched for 2027 and 2028 debentures; redemption notice for 2027 seriesCapital structure clean-up
Sep 23 / Oct 1, 2025$250 million 5.750% senior notes due 2032 priced and closedExtends maturities; lowers coupon against the 6.375% 2029 notes
Oct 2025Credit facility maturity extended to October 31, 2030Liquidity runway
Oct 7, 2025Units reach a then 52-week high of about $13.53Market recognition
Nov 3–4, 2025SIB results: $85.6 million of 2027s bought at $1,340 per $1,000; $39.5 million converted into 3.9 million units; $82.5 million of 2028s tendered ($73.9 million exchanged into non-convertible debentures)About 90% of convertibles eliminated in 2025
Nov 2025Q3 2025: record quarterly Adjusted EBITDA of $151.2 million on revenue of $532.8 million; guidance raised againPeak quarter of the cycle to date
Nov 21, 2025Polytec closesWater platform expanded
Dec 31, 2025General Counsel Susan Paré retiresExecutive transition
Jan 12, 2026District of North Vancouver council votes unanimously to send the rezoning to public hearingProcess milestone
Jan 21, 2026Distribution raised about 4% to $0.06 monthly; 2026 guidance of $485–$525 million issuedThird straight annual increase
Feb 20, 2026OTCQX trading begins (CGIFF)U.S. investor reach
Feb 25, 2026FY2025: revenue $1,997.8 million; record Adjusted EBITDA $507.4 million; 2026 guidance reaffirmedRecord year confirmed
Mar 20, 2026Annual Report, AIF and circular publishedAnnual disclosure cycle
Mid-April 2026District council rejects the rezoning; company says closure would affect chlorine supply nationallySharp negative catalyst; press commentary cites a roughly 20% unit price fall
April 2026NCIB in force with expiry April 16, 2027 for about 5.8 million units–
May 11, 2026Q1 2026: revenue $503.0 million (+7.9%); Adjusted EBITDA $113.5 million (-5.5%); first three-segment reporting; guidance reiteratedEC weakness offset by ASP and WS
May 12, 2026AGM; all eight trustees elected; say-on-pay approvedGovernance stability
May 21 – Jun 30, 2026Redemption of remaining 2028 convertibles; 1,651,738 units issued on conversion; $4.3 million redeemedNo convertible debt remains
Q2 2026Biennial North Vancouver turnaround completed (about $7.0 million EBITDA impact)Planned; in guidance
Jul 20, 2026District adopts rezoning bylaw with restrictive covenantReverses April rejection; tenure to 2046 at the latest
Jul 29, 2026Petition for judicial review filed in B.C. Supreme CourtNew legal overhang
Aug 12, 2026Q2 2026: revenue $578.7 million (+16.5%); Adjusted EBITDA $127.3 million (-7.8%); net earnings $42.9 million; guidance reiterated with weaker EC assumptionsH2-weighted year; leverage 2.55x
Aug 20 and Sep 18, 2026August and September distributions declared at $0.06Routine
Nov 11, 2026 (expected)Q3 2026 resultsNext catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Income Statement: Revenue & Gross Profit: Revenue rose from CAD 1,368.5 Mn in FY2021 to CAD 1,997.8 Mn in FY2025.
Chemtrade Logistics Inc. — Income Statement: Revenue & Gross Profit
Series (CAD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue1,368.51,813.41,846.81,7871,997.8
Cost of sales and services———1,356.51,537.7
Gross profit———430.6460.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.